推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-34243363

chinasupport@letpub.com

登录 注册 新注册优惠

[HTML] from ascopubs.orgEA Perez, EH Romond, VJ Suman… - Journal of Clinical …, 2011 - jco.ascopubs.org
Purpose Trastuzumab is a humanized monoclonal antibody against the human epidermal growth
factor receptor 2 (HER2). The clinical benefits of adjuvant trastuzumab have been demonstrated
in interim analyses of four large trials. Initial data of the combined analysis of the North ...
F Li… - Science, 2011 - sciencemag.org
CD40, a member of the tumor necrosis factor receptor (TNFR) superfamily, is expressed on
antigen-presenting cells (APCs) and is essential for immune activation. Although agonistic CD40
antibodies have been developed for immunotherapy, their clinical efficacy has been ...
Cited by 1
[HTML] from thelancet.comL Gianni, U Dafni, RD Gelber, E Azambuja… - The Lancet …, 2011 - Elsevier
The HERA trial is an international, multicentre, randomised, open-label, phase 3 trial comparing
treatment with trastuzumab for 1 and 2 years with observation after standard neoadjuvant, adjuvant
chemotherapy, or both in patients with HER2-positive early breast cancer. The primary ...
Cited by 7 - Related articles - All 7 versions
G Tang, S Shak, S Paik, SJ Anderson… - Breast cancer research …, 2011 - Springer
Abstract The Oncotype DX ® Recurrence Score® (RS) is a validated genomic predictor of outcome
and response to adjuvant chemotherapy in ER-positive breast cancer. Adjuvant! was developed
using SEER registry data and results from the Early Breast Cancer Clinical Trialists' ...
Cited by 2 - Related articles - All 4 versions
[HTML] from oxfordjournals.orgFA Sinicrope, NR Foster… - Journal of the …, 2011 - jnci.oxfordjournals.org
Methods We included stage II and III colon carcinoma patients (n = 2141) who were treated in
randomized trials of 5-FU-based adjuvant therapy. Tumors were analyzed for microsatellite instability
by polymerase chain reaction and/or for MMR protein expression by ...
Cited by 1 - Related articles - All 5 versions

联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

© 2010-2024 中国: LetPub上海    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)

增值电信业务经营许可证:沪B2-20211595    网络文化经营许可证:沪网文[2023]2004-152号

礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室